CRISPR-Cas9: Genome Engineering and Future Vaccine Applications
Molecular Biotechnology · 2026-07 · 68 (7) · 3068-3090
DOI: 10.1007/s12033-026-01563-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biotechnology, online erschienen am 16.03.2026. Verfasst von Masoumeh Madhi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Bacterial Vaccine, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Vaccines, Genetic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 151 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Bacterial Vaccine, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute, Karaj, Iran.
- Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. poorya.gholizadeh@gmail.com.
- Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. poorya.gholizadeh@gmail.com.
Zitieren
APA
Madhi, M., & Gholizadeh, P. (2026). CRISPR-Cas9: Genome Engineering and Future Vaccine Applications. Molecular Biotechnology, 68(7), 3068-3090. https://doi.org/10.1007/s12033-026-01563-4
Vancouver
Madhi M, Gholizadeh P. CRISPR-Cas9: Genome Engineering and Future Vaccine Applications. Molecular Biotechnology. 2026;68(7):3068-3090. doi:10.1007/s12033-026-01563-4
BibTeX
@article{Madhi2026,
author = {Madhi, Masoumeh and Gholizadeh, Pourya},
title = {CRISPR-Cas9: Genome Engineering and Future Vaccine Applications},
journal = {Molecular Biotechnology},
year = {2026},
volume = {68},
number = {7},
pages = {3068--3090},
doi = {10.1007/s12033-026-01563-4}
}
EUVIMED